Surgical Automations has successfully secured $3.4 million in an oversubscribed seed funding round to advance its innovative surgical robotics platform. Dr. Fred Moll, a pioneer in the field of surgical robotics and founder of Intuitive Surgical, co-led the funding alongside TurboStart, a venture capital firm based in Bengaluru, India. This funding will support the company’s mission to revolutionize gastrointestinal endoscopy through the integration of AI and automation.
Based in Dallas, Surgical Automations is developing the Vāsuki robotic system, which is designed to enhance upper and lower gastrointestinal diagnostic and interventional procedures. The company has made significant strides in robotics, advanced sensing, and AI-driven automated navigation, aiming to automate key steps in procedures like colonoscopies. This innovation promises to improve safety, speed, and precision for endoscopists.
Currently operating in stealth mode, Surgical Automations is focusing on advancing the Vāsuki system toward pre-clinical validation and initial human trials. The company’s efforts are driven by the urgent need to improve colorectal cancer screenings, which remain challenging and underserved by technology. TurboStart’s founder, Ganesh Raju, emphasized the importance of this endeavor, highlighting the company’s unique approach combining AI, robotics, and regulatory insight.
